Search Videos and More
Three Fox Chase Cancer Center Faculty Named to 2024 List of World’s Most Highly Cited Researchers
Fox Chase Cancer Center’s?Hossein Borghaei, DO, MS,?Elizabeth Plimack, MD, MS, and Lorenzo Galluzzi, PhD, have been named to the 2024 list of Highly Cited Researchers by Clarivate, a leading global provider of transformative intelligence.Fox Chase Cancer Center Earns Renewal of Prestigious Core Grant from the National Cancer Institute
Fox Chase Cancer Center, part of the Temple Health, has received a five-year renewal of its prestigious Cancer Center Support Grant (CCSG) from the National Cancer Institute (NCI), reaffirming its designation as an NCI-designated Comprehensive Cancer Center—an elite status held by only 57 centers nationwide.Bonds That Last a Lifetime for a Fox Chase Fellow
When I arrived, I clicked right away with Jeffrey M. Farma, MD, FACS, now Chair of the Department of Surgery.23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.Transforming Treatment for Chronic Lymphocytic Leukemia Patients
Over the past 10 years, the treatment landscape and prognosis for Chronic Lymphocytic Leukemia (CLL) has dramatically improved, even among older adults.GYNECOLOGIC CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and SurvivorshipFox Chase Cancer Center Fellow Dr. Joseph Van Galen Awarded American Society of Clinical Oncology Young Investigator Award
Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer CenterMarried People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows
Namrata Vijayvergia, MD, Section Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer CenterElectronic Health Record Intervention Boosts Fertility Preservation for Young Cancer Patients at Fox Chase Cancer Center
Christopher Cann, MD, Director of the Young Adult Cancer Program and Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer CenterLocal Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.A tragic death becomes a life force.
“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience p

